Jolanta Kalwat-Smok

Kielce, SK, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study.

Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study.

Journal: Journal of neuro-oncology

Published: December 03, 2025

Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central Europe.

Effectiveness of sacituzumab govitecan in metastatic triple-negative breast cancer: a real-world retrospective cohort study from Central Europe.

Journal: The oncologist

Published: November 23, 2025

Impact of Germline BRCA1/2 Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan-An International CEBCC Study from Poland, the Czech Republic and Slovakia.

Impact of Germline BRCA1/2 Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan-An International CEBCC Study from Poland, the Czech Republic and Slovakia.

Journal: Oncology research

Published: November 19, 2025

Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study.

Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study.

Journal: Breast (Edinburgh, Scotland)

Published: October 28, 2025

Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2- advanced breast cancer: A multicenter retrospective study.

Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2- advanced breast cancer: A multicenter retrospective study.

Journal: Breast (Edinburgh, Scotland)

Published: October 12, 2025

Enoxacin-fatty acid conjugates: Synthesis and assessment of antibacterial and anticancer potentials.

Enoxacin-fatty acid conjugates: Synthesis and assessment of antibacterial and anticancer potentials.

Journal: European journal of medicinal chemistry

Published: July 15, 2025

Toll-like Receptors: Key Players in Squamous Cell Carcinoma Progression.

Toll-like Receptors: Key Players in Squamous Cell Carcinoma Progression.

Journal: Journal of clinical medicine

Published: July 10, 2024

FTIR monitoring of the 13-valent pneumococcal conjugate vaccine for lung cancer patients: Changes in amides vibrations correlated with biochemical assays.

FTIR monitoring of the 13-valent pneumococcal conjugate vaccine for lung cancer patients: Changes in amides vibrations correlated with biochemical assays.

Journal: Vaccine

Published: June 14, 2024

Serum and plasma as a good candidates of body fluids for detection lung cancer by FTIR liquid biopsy.

Serum and plasma as a good candidates of body fluids for detection lung cancer by FTIR liquid biopsy.

Journal: Scientific reports

Published: May 11, 2024

Analysis of Selected Toll-like Receptors in the Pathogenesis and Advancement of Non-Small-Cell Lung Cancer.

Analysis of Selected Toll-like Receptors in the Pathogenesis and Advancement of Non-Small-Cell Lung Cancer.

Journal: Journal of clinical medicine

Published: April 11, 2024

Enhancing Immune Response in Non-Small-Cell Lung Cancer Patients: Impact of the 13-Valent Pneumococcal Conjugate Vaccine.

Enhancing Immune Response in Non-Small-Cell Lung Cancer Patients: Impact of the 13-Valent Pneumococcal Conjugate Vaccine.

Journal: Journal of clinical medicine

Published: January 20, 2024

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice.

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice.

Journal: Frontiers in oncology

Published: November 19, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026